- Report
- February 2022
- 40 Pages
Vietnam
From €1466EUR$1,500USD£1,224GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- November 2024
- 65 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- October 2024
Global
From €3420EUR$3,500USD£2,855GBP
- Report
- August 2024
- 48 Pages
China
From €1759EUR$1,800USD£1,468GBP
- Report
- August 2024
- 199 Pages
China
From €3908EUR$4,000USD£3,263GBP
- Report
- August 2024
- 98 Pages
China
From €1759EUR$1,800USD£1,468GBP
- Report
- July 2024
- 280 Pages
Global
From €2594EUR$2,655USD£2,166GBP
The Colon Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy.
Chemotherapy drugs are used to kill cancer cells and stop them from growing. Targeted therapy drugs are designed to target specific cancer cells and block their growth. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer cells.
Some of the major companies in the Colon Cancer Drugs market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and marketing of drugs used to treat colon cancer. Show Less Read more